Koyfin Home > Directory > Health Care > Akebia Therapeutics > Levered Free Cash Flow (FCF)

Akebia Therapeutics Levered Free Cash Flow (FCF) Chart (AKBA)

Akebia Therapeutics annual/quarterly Levered Free Cash Flow (FCF) from 2013 to 2020.
  • Akebia Therapeutics Levered Free Cash Flow (FCF) for the quarter ending June 06, 2020 was $50m a -2.34% decrease of -1m year over year
  • Akebia Therapeutics Levered Free Cash Flow (FCF) for the last 12 months ending June 06, 2020 was $-29m a -537.09% increase of 156m year over year
  • Akebia Therapeutics Annual Levered Free Cash Flow (FCF) for 2019 was $-150m a 53.02% decrease of -80m from 2018
  • Akebia Therapeutics Annual Levered Free Cash Flow (FCF) for 2018 was $-71m a 74.76% decrease of -53m from 2017
  • Akebia Therapeutics Annual Levered Free Cash Flow (FCF) for 2017 was $-18m a 27.87% decrease of -5m from 2016
Other Cash Flow Metrics:
  • Akebia Therapeutics Cash Flow from Operations for the quarter ending December 12, 2018 was $-74m a 72.41% decrease of -53m year over year
  • Akebia Therapeutics Total Revenue for the quarter ending December 12, 2018 was $60m a 23.26% increase of 14m year over year
View Chart On Koyfin

Quarterly AKBA Levered Free Cash Flow (FCF) Data

06/2020$50m
03/2020$-74m
12/2019$-57m
09/2019$52m
06/2019$-32m
03/2019$-114m
12/2018$-92m
09/2018$-4m
06/2018$32m
03/2018$-6m

Annual AKBA Levered Free Cash Flow (FCF) Data

2019$-150m
2018$-71m
2017$-18m
2016$-13m
2015$-30m
2014$-16m
2013$-6m
2012$-7m